We came across a bullish thesis on AbbVie Inc. (ABBV) on Substack by Magnus Ofstad. In this article, we will summarize the bulls thesis on ABBV. AbbVie Inc. (ABBV)'s share was trading at $198.47 as o… [+2277 chars]...
Read moreDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarke… [+7225 chars]...
Read moreSOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced … [+5658 chars]...
Read moreDublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains … [+5806 chars]...
Read moreDublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Market Report 2025" has been added to ResearchAndMarkets.com's offering. The anti-cancer monoclonal antibodies (mAbs) market is experie… [+6226 chars]...
Read moreCompeting interests TP: honorarium: Amgen, Servier, MSD; advisory board: Amgen, Servier, MSD and BMS. IL: Roche, MSD, Amgen, BMS, Pfizer, Ryvu, Takeda Siropa, Rhizen, Menarini, Incyte and MacroGenics… [+5619 chars]...
Read more